The sold production of diagnostic reagents and other pharmaceutical preparations in Spain has shown a robust growth trajectory from 2013 to 2022, with an average annual growth rate (CAGR) of 5.37% over the last five years, culminating in a value of 115.6 million Euros in 2023. The year-on-year variation for 2023 stood at 7.86%, indicating a healthy upward trend despite minor fluctuations, such as a notable dip in 2020 due to external factors likely related to the COVID-19 pandemic.
Future projections from 2024 to 2028 suggest a continued growth path, with a forecasted CAGR of 3.01%. By 2028, the market is expected to reach approximately 139.78 million Euros, representing a forecasted growth rate of 15.97% over this period.
- Future trends to watch for:
- Technological advancements and innovations in diagnostic reagents.
- Global and regional healthcare policy changes.
- Shifts in pharmaceutical R&D investments and production capacities.
- Emerging health threats and their impact on diagnostic needs.
